Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Evaluating the Feasibility of Delivering a Biobehavioral Stress Reduction Intervention in Patients with Stage I-III Triple Negative Breast Cancer

Trial Status: active

This clinical trial evaluates the feasibility of delivering a biobehavioral stress reduction intervention for reducing stress levels in patients with stage I-III triple negative breast cancer. Patients with triple negative breast cancer have been shown to have higher rates of death due to adverse social aspects of health. Stress in particular results in suppression of the immune response, which can prevent wound healing and intensify tumor progression. This biobehavioral stress reduction intervention includes muscle relaxation techniques, coping skills, as well as problem solving and social support sessions, which may help improve health outcomes in this population of cancer patients.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.